Kyntra Bio, Inc. (KYNB) — Cash Flow Reinvestment Rate
Kyntra Bio, Inc. (KYNB) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting $13.00K (capex $13.00K ) from operating cash flow of $12.68 Million. Explore KYNB capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kyntra Bio, Inc. Cash Flow Reinvestment Rate (2013–2020)
Historical reinvestment intensity for Kyntra Bio, Inc. across 4 annual periods. Also explore Kyntra Bio, Inc. (KYNB) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Kyntra Bio, Inc. (2013–2020)
Year-by-year capital reinvestment analysis for Kyntra Bio, Inc.. For live market cap and broader valuation context, see Kyntra Bio, Inc. market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.05x | $3.99 Million | $81.60 Million | $3.99 Million | ▼ -72.2% |
| 2016 | 0.18x | $1.25 Million | $7.11 Million | $1.25 Million | ▼ -51.4% |
| 2014 | 0.36x | $8.12 Million | $22.41 Million | $8.12 Million | ▲ +37.9% |
| 2013 | 0.26x | $6.81 Million | $25.92 Million | $6.81 Million | — |